MyFinsight
Home
Blog
About
Cash
$5,028K
Prepaid expenses and
other current assets
$783K
Due from related
party
$83K
Total current assets
$5,894K
Right-of-use assets -
operating leases, net
$314K
Property and equipment,
net
$82K
Other assets
$25K
Total assets
$6,315K
(-16.73%↓ Y/Y)
Total liabilities and
stockholders equity
$6,315K
(-16.73%↓ Y/Y)
Total stockholders
equity
$3,200K
(-27.99%↓ Y/Y)
Total liabilities
$3,115K
(-0.80%↓ Y/Y)
Accumulated deficit
-$255,159K
(-5.05%↓ Y/Y)
Additional paid-in capital
$258,352K
(4.47%↑ Y/Y)
Total current
liabilities
$2,932K
(10.60%↑ Y/Y)
Operating lease
liabilities, non-current
$182K
(-51.60%↓ Y/Y)
Other liabilities
$1K
(-99.12%↓ Y/Y)
Common stock, 0.005 par
value, 150,000 shares...
$6K
(-83.78%↓ Y/Y)
Preferred stock, 0.005 par
value, 1,000 shares...
$1K
(0.00%↑ Y/Y)
Accounts payable
$1,375K
(4.25%↑ Y/Y)
Accrued expenses
$1,016K
(8.32%↑ Y/Y)
Due to related party
$250K
Operating lease
liabilities, current
$167K
(-23.04%↓ Y/Y)
Other current
liabilities
$124K
(-0.80%↓ Y/Y)
Back
Back
Balance Sheet
Ernexa Therapeutics Inc. (ERNA)
Ernexa Therapeutics Inc. (ERNA)
source: myfinsight.com